ETV5 and diffuse large B-cell lymphoma: As predicted, treatment with Y-27632 also decreased the phosphorylation of the ezrin/radixin/moesin (ERM) proteins, classic targets for both ROCK1 and ROCK2, in all DLBCL cell lines examined (Fig. 1c).